CD27 signals through PKC in human B cell lymphomas

Cytokine

Volumn 11, Issue 7, 1999, Pages 476-484

  Erlichman, Beth ^a   Zack Howard, O M ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

B cell; CD27; Lymphoma; PKC; Signal transduction

Indexed keywords

CD27 ANTIGEN; CD70 ANTIGEN; IMMUNOGLOBULIN G; PROTEIN KINASE C;

ARTICLE; B CELL LYMPHOMA; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SIGNAL TRANSDUCTION;

EID: 0345517978     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0449     Document Type: Article

References (41)

1. Lotz M, Setareh M, vonKempis J, Schwarz H. The nerve growth factor/tumor necrosis factor receptor family. J Leukoc Biol. 60:1996;1-7.
2. Gruss H-J, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood. 85:1995;3378-3404.
3. Rui H, Kirken RA, Duhe RJ, Howard OMZ, Evans GA, Farrar WL. Lymphokine-induced signal transduction. Townley R, Agrawal DK. Immunopharmacology of allergic diseases. 1996;29-77 Marcell Dekker, Inc. New York.
4. Hintzen RQ, de Jong R, Lens SMA, van Lier RAW. CD27: marker and mediator of T-cell activation. Immunol Today. 15:1994;307-311.
5. +T cell subset. Eur J Immunol. 18:1988;811-816.
6. +Naive T Cell Costimulation. J Immunol. 153:1994;5422-5432.
7. Hintzen RQ, Lens SMA, Lammers K, Kuiper H, Beckmann MP, van Lier RAW. Engagement of CD27 with its ligand CD70 provides a second signal for T Cell activation. J Immunol. 154:1995;2612-2623.
8. Agematsu K, Kobata T, Sugita K, Hirose T, Schlossman SF, Morimoto C. Direct cellular communication between CD45RO and CD45RA T cell subsets via CD27/CD70. J Immunol. 154:1995;3627-3635.
9. Hintzen RQ, de Jong R, Hack E, Chamuleau M, de Vries EFR, ten Berge IJM, Brost J, van Lier RAW. A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J Immunol. 147:1991;29-35.
10. Yang FC, Agematsu K, Nakazawa T, Mori T, Ito S, Kobata T, Morimoto C, Komiyama A. CD27/CD70 interaction directly induces natural killer cell killing activity. Immunology. 88:1996;289-293.
11. Sugita K, Robertson MJ, Torimoto Y, Ritz J, Schlossman SF, Morimoto C. Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells. J Immunol. 149:1992;1199-1203.
12. Kobata T, Jacquot S, Kozlowski S, Agematsu K, Schlossman SF, Morimoto C. CD27-CD70 interaction regulated B-cell activation by T-cells. Proc Natl Acad Sci USA. 92:1995;11249-11253.
13. Agematsu K, Kobata T, Feng-Chun Y, Nakazawa T, Nakazawa T, Fukushima K, Kitahara M, Mori T, Sugita K, Morimoto C, Komiyama A. CD27/CD70 interaction directly drives B cell IgG and IgM synthesis. Eur J Immunol. 25:1995;2825-2829.
14. Lens SMA, De Jong R, Hintzen RQ, Koopman G, Van Lier RAW, Van Oers RHJ. CD27-CD70 interaction: unravelling its implication in normal and neoplastic B-cell growth. Leukemia and Lymphoma. 18:1995;51-59.
15. Trentin L, Zambello R, Sancetta R, Facco M, Cerutti A, Perin A, Siviero M, Basso U, Bortonlin M, Adami F, Agostini C, Semenzato G. B Lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res. 57:1997;4940-4947.
16. Van Oers MH, Pals ST, Evers LM, van der Schoot CE, Koopman G, Bonfrer J, Hintzen RQ, von dem Borne AE, van Lier RAW. Expression and release of CD27 in human B-cell malignancies. Blood. 82:1993;3430-3436.
17. +B cells and helper T cells in immunoglobulin production. Eur J Immunol. 27:1997;2073-2079.
18. Agematsu K, Nagumo H, Oguchi Y, Nakazawa T, Fukushima K, Yasui K, Ito S, Kobata T, Morimoto C, Komiyama A. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood. 91:1998;173-180.
19. Winter JN, Variakojis D, Epstein AL. Phenotypic analysis of established diffuse histiocytic lymphoma cell lines utilizing monoclonal antibodies and cytochemical techniques. Blood. 63:1984;140-146.
20. Lankester AC, Rood PML, van Schijndel GMW, Hooibrink B, Verhoeven AJ, van Lier RAW. Alteration of B-cell antigen receptor signaling by CD19 co-ligation. J Biol Chem. 271:1996;22326-22330.
21. Beckwith M, Fenton RG, Katona IM, Longo DL. Phosphatidylinositol-3-kinase activity is required for the anti-Ig-mediated growth inhibition of B-lymphoma cell line. Blood. 87:1996;202-210.
22. Yunis JJ. The chromosomal basis of human neoplasia. Science. 221:1983;227-236.
23. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosomal breakpoint of neoplastic B cells with the t(14:18) chromosome translocation. Science. 226:1984;1097-1099.
24. Wendtner CM, Schmitt B, Gruss HJ, Druker BJ, Emmerich B, Goodwin R, Hallek M. CD30 ligand signal transduction involves activation of a tryrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell lines. Cancer Res. 55:1995;4157-4161.
25. Goodwin RG, Alderson MR, Smith CA, Armitage RJ, Vanden Bos T, Jerzy R, Tough TW, Schoenborn MA, Davis-Smith T, Hennen K, Falk B, Cosman D, Baker E, Sutherland GR, Grabstein KH, Farrah T, Giri JG, Beckmann MP. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell. 73:1993;447-456.
26. Mayumi M, Ohshima Y, Hata D, Kim KM, Heike T, Katamura K, Furusho K. IgM-mediated B cell apoptosis. Crit Rev Immunol. 15:1995;255-269.
27. Beckwith M, Longo DL, O'Connell CK, Moratz CM, Urba WJ. Phorbol ester-induced, cell-cycle-specific, growth inhibition of human B lymphoma cell lines. J Natl Cancer Inst. 82:1990;501-509.
28. Devesa SS, Silverman DT, Young JL, Pollack ES, Brown CC, Horm JW, Percy CL, Myers MH, McKay FW, Fraumeni JF. Cancer incidence and mortality trends among whites in the United States 1947-1984. J Natl Cancer Inst. 79:1987;701-770.
29. Roos MThL, de Leeuw NASM, Claessen FAP, Huisman HG, Kootstra NA, Meyaard L, Schellekens PThA, Schuitemaker H, Miedema F. Viro-immunological studies in acute HIV-1 infection. AIDS. 8:1994;1533-1538.
30. Meyaard L, Kuiper H, Otto SA, Wolthers KC, van Lier RAW, Miedema F. Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals. Eur J Immunol. 25:1995;232-237.
31. Yazdanbakhsh M, Sartono E, Kruize YCM, Kurniawan A, van der Pouw-Kraan T, van der Meide PH, Selkirk ME, Partono F, Hintzer RQ, van Lier RAW, Maizels RM. Elevated levels of T cell activation antigen CD27 and increased interleukin-4 production in human lymphatic filariasis. Eur J Immunol. 23:1993;3312-3317.
32. Jacquot S, Kobata T, Iwata S, Morimoto C, Schlossman SF. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T Cell dependent B Cell responses. J Immunol. 159:1997;2652-2657.
33. Muramatsu M, Akasaka T, Kadowaki N, Ohno H, Fukuhara S, Okuma M. Rearrangements of the BCL6 gene in B-cell lymphoid neoplasms. Leukemia Suppl. 3:1997;318-320.
34. Mauvieux L, MacIntyre EA. Practical role of molecular diagnostics in non-Hodgkins lymphomas. Baillières Clin Heamatol. 9:1996;653-667.
35. Haldar S, Basu A, Croce CM. Bcl2 is the guardian of microtubule integrity. Cancer Res. 57:1997;229-233.
36. Prasad KVS, Ao Z, Yoon Y, Wu MX, Rizk M, Jacquot S, Schlossman SF. CD27, a member of the tumor necrosis factor receptor family induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci USA. 94:1997;6346-6351.
37. Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, Atsuta M, Morimoto C, Ware C, Malinin NL, Wallach D, Yagita H, Okumura K. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kB and stress-activated protein kinase/c-June N-terminal kinase via TRAF2, TRAF5, and Nf-kB-inducing kinase. J Biol Chem. 273:1998;13353-13358.
38. Messineo C, Jamerson MH, Hunter E, Braziel R, Bagg A, Irving SG, Cossman J. Gene expression by single Reed-Sternberg cells: pathways of apoptosis and activation. Blood. 91:1998;2443-2451.
39. Jaken S. Protein kinase C isozymes and substrates. Current Opin Cell Bio. 8:1996;168-173.
40. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K. PKCζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14:1995;1961-1969.
41. Hiddemann W, Longo DL, Coiffier B, Fisher RI, Cabanillas F, Cavalli F, Nadler LM, De Vita VT, Lister TA, Armitage JO. Lymphoma Classification - The gap between biology and clinical management is closing. Blood. 88:1996;4085-4089.